Christopher Hix is recorded as CFO at Enovis CORP (ENOV). The newest filing on record that lists Christopher Hix as CFO at Enovis CORP (ENOV) is dated March 31, 2023. Enovis CORP reported in an 8-K filed January 3, 2023 that Christopher Hix retired as Executive Vice President and Chief Financial Officer, effective December 31, 2022. The proxy statement of Enovis CORP reports total compensation of $4,475,412 for Christopher Hix in fiscal 2022, including a base salary of $650,000. Disclosed compensation is on record for 6 fiscal years. Christopher Hix has spoken on 3 earnings calls across 1 company, most recently for Enovis CORP on March 31, 2022. Enovis CORP is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Enovis CORP includes Damien McDonald (CEO and Board Member), Matthew L. Trerotola (CEO, Chairman and Board Member), Sharon Wienbar (Chairman and Board Member) and 7 others.
“Christopher M. Hix retired from his position as the Company's Executive Vice President and Chief Financial Officer and ceased to serve as the Company's principal financial officer on December 31, 2022”
Enovis CORP Form 8-K, filed January 3, 2023
· Read the filing
Christopher Hix on recent calls
“And thank you for joining us today for our first earnings call since we launched Enovis and on the call today, of course is also Matt Trerotola, our Chief Executive Officer.”
“Revenue levels continue to recover as we've been expecting. The MedTech business is solidly growing past 2019 levels, including the Recon platform at 10% on a daily rate basis.”
“As Matt mentioned earlier, we have a strong balance sheet with significant liquidity. At the end of the quarter, we had $366 million of cash and over $900 million of borrowing capacity for total liquidity of nearly $1.3 billion.”
